Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides

Yvonne Adams, Craig Freeman, Reinhard Schwartz-Albiez, Vito Ferro, Christopher R. Parish, Katherine T. Andrews*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Abstract

    A panel of sulfated oligosaccharides was tested for antimalarial activity and inhibition of adhesion to the placental malaria receptor chondroitin-4-sulfate (CSA). The heparan sulfate mimetic PI-88, currently undergoing phase II anticancer trials, displayed the greatest in vitro antimalarial activity against Plasmodium falciparum (50% inhibitory concentration of 7.4 μM) and demonstrated modest adhesion inhibition to cell surface CSA.

    Original languageEnglish
    Pages (from-to)2850-2852
    Number of pages3
    JournalAntimicrobial Agents and Chemotherapy
    Volume50
    Issue number8
    DOIs
    Publication statusPublished - Aug 2006

    Fingerprint

    Dive into the research topics of 'Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides'. Together they form a unique fingerprint.

    Cite this